UK biotech flagship meets stormy waters

Ehsan Masood

Nature, 1998, vol. 392, issue 6678, 746-746

Abstract: london Britain's leading biotechnology company has sacked its director of clinical research for allegedly disclosing confidential information to one of the company's investors.

Date: 1998
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/33758 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:392:y:1998:i:6678:d:10.1038_33758

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/33758

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().